DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1155727
Title:
Treatment Options and Survival of Metastatic Prostate Cancer Patients
Report Date:
2021-06-01
Abstract:
In this proposal, we will utilize a prostate cancer cohort from the VA hospitals to explore the survival benefit among men diagnosed with metastatic prostate cancer who receive definitive treatment (alone or with adjuvant therapies) compared to men who receive non-definitive treatment; and we will assess the treatment related side effects that affect quality of life among men diagnosed with metastatic prostate cancer who receive definitive vs. non-definitive treatment. The specific aims are: Aim 1: To examine the survival benefit among men diagnosed with metastatic prostate cancer that receive definitive treatment compared to men that receive non-definitive treatment. Aim 2: To examine treatment-related side effects that affect quality of life (impotence, incontinence and pain) among men diagnosed with metastatic prostate cancer that receive definitive treatment compared to men that receive non-definitive treatment.
Document Type:
Conference:
Journal:
Pages:
10
File Size:
0.39MB
W81XWH-19-1-0214
(W81XWH1910214);
Contracts:
Grants:
Distribution Statement:
Approved For Public Release
